• A number of chemotherapeutic agents have been shown to have antitumor activity against childhood medulloblastoma. Ten-year survival with optimal surgery and radiation therapy ranges from 5% to 25%. Carefully controlled clinical trials utilizing a combination of surgery, radiation therapy, and chemotherapy should be employed in the early stages of the disease in an attempt to define which drugs are most effective, and to improve the survival rate.
(Am J Dis Child 130:639-642, 1976)
Crist WM, Ragab AH, Vietti TJ, Ducos R, Chu J. Chemotherapy of Childhood Medulloblastoma. Am J Dis Child. 1976;130(6):639–642. doi:10.1001/archpedi.1976.02120070065013
Artificial Intelligence Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.